Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT06842017
Enrolling by invitation Not applicable

Passive Exoskeletons for Assisting Patients With Shoulder Musculoskeletal Disorders

NCT06842017 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2025-05-28
Last updated
2025-08-11

Condition(s) studied

Shoulder Musculoskeletal Disorders

Investigational drug(s) / intervention(s)

Passive Exoskeleton.Shoulder Rehabilitation with Passive Exoskeleton.Usability Assessment and Patient Satisfaction.

Passive Exoskeleton.: The passive exoskeleton is used to assist patients with shoulder musculoskeletal disorders during the performance of activities of daily living (ADLs), such as overhead reaching and lifting. The device helps reduce biomechanical load and muscle strain, providing support for the shoulder joint.

Shoulder Rehabilitation with Passive Exoskeleton.: The rehabilitation protocol involves the use of a passive exoskeleton during physical tasks to improve shoulder function and reduce pain. Patients perform specific exercises while wearing the exoskeleton, which is tailored to their individual needs.

Usability Assessment and Patient Satisfaction.: The usability of the passive exoskeleton is evaluated using validated scales, such as the System Usability Scale (SUS), to assess its comfort, effectiveness, and overall satisfaction. The assessment also includes patient feedback on the ease of use and perceived benefits of the device during rehabilitation sessions.

Study summary

Goal: The clinical investigation aims to evaluate the usability of passive exoskeletons, their impact on daily living activities, and the perceived experience of patients with shoulder musculoskeletal disorders. This will be assessed through specific validated questionnaires.

Participant Population: The study will enroll 15 participants diagnosed with shoulder musculoskeletal disorders, including rotator cuff tears, adhesive capsulitis, and glenohumeral osteoarthritis. Participants must be employed in physically demanding jobs that require frequent upper limb activity.

Main Questions:

* How does the integration of passive exoskeletons in daily activities influence usability and functional performance in patients with shoulder musculoskeletal disorders?
* To what extent does the use of passive exoskeletons improve the perceived physical effort and quality of life in these patients?
* How do patients perceive the comfort and effectiveness of passive exoskeletons during the execution of daily living tasks?

Participant Tasks:

* Comprehensive shoulder physical examination. Instruction on the proper use of the Paexo passive exoskeleton and customization of its settings.
* Execution of workplace-relevant tasks (e.g., lifting, overhead reaching) with and without the exoskeleton.
* Evaluation of usability, comfort, and perceived workload using validated scales such as the System Usability Scale (SUS), NASA Task Load Index (NASA-TLX), and Technology Acceptance Model (TAM).

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria * Age over 18 years. * Employment in a physically demanding job requiring frequent upper limb activity. * Diagnosis of one of the following conditions related to shoulder musculoskeletal disorders: rotator cuff tears, massive tears with pseudoparalytic limb, adhesive capsulitis, post-surgical outcomes following rotator cuff repair or reverse shoulder arthroplasty, and glenohumeral osteoarthritis. * Signed informed consent. Exclusion Criteria * Failure to provide signed informed consent. * Any condition that hinders the use of exoskeletons. * Insufficient cognitive or language abilities to follow instructions provided by clinicians and/or investigators. * Pregnancy.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fondazione Policlinico Universitario Campus Bio-Medico Rome Italy

More Fondazione Policlinico Universitario Campus Bio-Medico trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06842017 on ClinicalTrials.gov ↗ ← All trials in Italy